Cardiology Diagnostic Methods

Non-Invasive Methods
Electrocardiography (ECG)
Exercise Stress Test (Treadmill Exercise Test, Cardiovascular Stress Test)
Transthoracic Echocardiography (TTE)
Transesophageal Echocardiography (TEE)
Stress Echocardiography (Stress Echo, Dobutamine Stress Echocardiography – DSE)
Holter Monitoring (ECG/Rhythm Holter)
Ambulatory Blood Pressure Monitoring (Blood Pressure Holter)
Tilt Table Test
Non-Invasive Cardiac Hemodynamic Monitoring (Impedance Cardiography)
Pacemaker and Implantable Cardioverter-Defibrillator (ICD) Follow-Up and Interrogation
Invasive Methods
Cardiac Catheterization
Coronary Angiography
Pulmonary Vasoreactivity Testing
Fractional Flow Reserve (FFR) Measurement
Renal Angiography and Peripheral Angiography
Electrophysiological Study (EPS)
Endomyocardial Biopsy (Cardiac Biopsy)

TREATMENT METHODS AVAILABLE IN OUR DEPARTMENT
Coronary Angioplasty and Stent Placement
Primary Angioplasty and Stent Placement (24/7)
Renal Angioplasty and Stent Placement
Peripheral Angioplasty and Stent Placement
Percutaneous Mitral Balloon Valvuloplasty
Percutaneous Pulmonary Balloon Valvuloplasty
Percutaneous Closure of Congenital Heart Defects (ASD / PFO / PDA) Using Occluder Devices
Percutaneous Pericardiocentesis and Drainage with a Pigtail Catheter
Temporary and Permanent Pacemaker Implantation
Implantable Cardioverter-Defibrillator (ICD) Implantation
Radiofrequency Catheter Ablation for the Treatment of Arrhythmias
Cardiac Resynchronization Therapy (Biventricular Pacemaker)
Transcatheter Aortic Valve Implantation (TAVI)
Percutaneous ASD Closure

Additional Treatment Options

When clinically indicated, the following treatment options are also available to our patients:

Cascade LDL Lipid Apheresis: A treatment option provided in collaboration with the Apheresis Unit of the Division of Hematology, Department of Internal Medicine, for patients with familial hypercholesterolemia.
Heart Transplantation: A treatment option provided in collaboration with the Department of Cardiovascular Surgery for patients with end-stage heart failure.